The Benefits of Jakafi for Patients With PV

Article

Patients with PV tend to be very symptomatic, but Jakafi can help.

Jeanne M. Palmer, M.D., hematologist oncologist at the Mayo Clinic in Arizona discusses the benefit of Jakafi (ruxolitinib) for patients with polycythemia vera (PV) — a type of myeloproliferative neoplasm.

Patients with PV tend to be very symptomatic, and Jakafi provides good symptom control compared to some other PV treatments that have their own set of risks and side effects.

Recent Videos
Image of a woman with brown wavy hair, wearing a navy blue top.
Image of a man wearing a suit with a red bowtie.
Image of a man with rectangular glasses and a goatee.
Image of a woman with glasses and dark hair.
Image of a woman wearing a red tank top.
Image of a woman with a brown hair tied into a bun.
Image of Annie Bond.
Related Content
doctor with blood vials

A True Partner in Cancer Healing

Wendy Stock, MD
September 1st 2024
Article

Keri is also a true partner in the management and care of the whole patient.

Read More

Cancer Horizons podcast logo

FDA Stops Lung Cancer Trial, CAR-T Cell Therapy Is Cost Effective, Novel Drug Slows Fibrosis

Alex Biese;Brielle Benyon
January 8th 2024
Podcast

The year 2024 is now underway. After a busy 2023, we’re now looking back at some of the oncology headlines from the new year.

Listen

Illustration of a woman with long blonde hair, wearing sunglasses.

8 Things to Do While in the Hospital for Cancer Treatment

Mary Sansone
August 26th 2024
Article

While spending weeks in the hospital for acute myeloid leukemia, I tried eight fun things to keep me busy.

Read More

LeVar Burton Helping the MPN Community Through Advocacy and Storytelling

LeVar Burton Helping the MPN Community Through Advocacy and Storytelling

Jamie Cesanek;Darlene Dobkowski, MA
December 16th 2021
Podcast

On this episode of the “Cancer Horizons” podcast, LeVar Burton sits down with CURE® to talk about the importance of MPN awareness and the power of storytelling in advocacy.

Listen

Illustration of MPN blood cancer.

5 Factors Linked to Greater Chance of Polycythemia Vera Progression

Megan Hollasch
July 23rd 2024
Article

Researchers identified five traits that may increase a person’s chance of experiencing polycythemia vera progression.

Read More

Image of a man wearing a light blue polo shirt.

Radiation a Curative-Intent Option in NSCLC and Interstitial Lung Disease

Alex Biese
July 18th 2024
Article

For some patients with early non-small cell lung cancer and lung scarring, stereotactic ablative radiotherapy may be a viable option, research has shown.

Read More